IMNM vs IMVT Stock Comparison
IMVT currently leads IMNM in this stock comparison, with AIQ scores of 52 vs 48. The clearest difference is momentum, while IMNM has the stronger quality profile.
What is the main difference between IMNM and IMVT?
IMVT leads the current stock comparison as Immunovant, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Immunome, Inc. vs Immunovant, Inc.
IMVT leads
IMVT leads by 4 AIQ points, primarily on Momentum and Risk Resilience, having only recently taken the lead back from IMNM.
Fragile: 4 of 4 evidence groups support IMVT, the lead recently changed hands, and its current signal state is conflicted.
Immunome, Inc.
Immunovant, Inc.
The Algovestiq AIQ Score currently favors IMVT over IMNM, 52 versus 48 as of Nov 15, 2026. IMVT's advantage is driven primarily by stronger momentum and risk resilience, while IMNM holds the stronger quality profile. IMVT also shows the stronger technical structure relative to its 50-day moving average. 4 of 4 covered evidence groups favor IMVT today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 4 points. IMVT lead: Reversed — IMNM led by 2 AIQ points 30 sessions ago; IMVT now leads by 4.
Compare Immunome, Inc. and Immunovant, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare IMNM and IMVT against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum45 vs 61IMVT +16
- Quality52 vs 42IMNM +10
- Risk Resilience47 vs 52IMVT +5
4 of 4 evidence groups favor IMVT. IMVT’s edge is concentrated in momentum and risk resilience; IMNM keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum +2
New signals
- ADX Trend Weakening — neutral, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.63x)
Largest factor move: Momentum +3
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
IMVT's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — IMNM and IMVT both carry a full feed there.
The central trade-off
IMVT (Immunovant, Inc.): the stronger current systematic profile, led by momentum and risk resilience.
IMNM (Immunome, Inc.): the counter-case, on quality.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
IMVTIMVT on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
IMNMIMNM on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
IMVTIMVT on the Momentum factor, by 16 points.
Lower downside
IMVTIMVT on Risk Resilience, by 5 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | IMNM | IMVT | Note |
|---|---|---|---|
| Implied upside to target | +43.8% | — | Level |
| Target dispersion | +22.2% | — | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 17 | 17 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 4 covered evidence groups favor IMVT. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | IMVT | 48 vs 52 |
| Fundamentals | IMVT | EPS growth -16.9% vs 37.3%; TTM ROE -18.9% vs -14.8% |
| Valuation | Not covered | Not covered |
| Technicals | IMVT | Price vs 50-day -9.1% vs 4.7%; vs 200-day -15.5% vs 5.7% |
| Risk Resilience | IMVT | Risk Resilience 47 vs 52 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of IMNM and IMVT and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 4 points. (argues the conclusion is provisional)
- 4 of 4 covered evidence groups point the same way. (supports the conclusion holding)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on IMVT.
How the comparison changed
120 daily snapshots · May 27 – Nov 13IMVT lead: Reversed — IMNM led by 2 AIQ points 30 sessions ago; IMVT now leads by 4.
- Today
- IMVT +4
- 48 vs 52
- 7 sessions ago
- IMNM +1
- 50 vs 49
- 30 sessions ago
- IMNM +2
- 51 vs 49
- 90 sessions ago
- IMVT +2
- 64 vs 66
The lead changed hands 2 times in this window, most recently on Nov 9 when IMVT moved ahead of IMNM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 3 bearish / 2 neutral
Only IMNM
- Death Cross Active — bearish, trend, long horizon (7.56%)
- ADX Trend Weakening — neutral, trend, medium horizon
- Downtrend Structure Active — bearish, trend, long horizon
4 bullish / 3 bearish / 1 neutral, conflicted
Only IMVT
- Golden Cross Active — bullish, trend, long horizon (0.90%)
- Beta Spike Warning — bearish, risk_regime, long horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- RSI Bearish Divergence — bearish, momentum, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, Low Volume Rally Warning.
IMVT leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +0.37%, AIQ +1 points).
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.48%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1IMNM closes the Momentum gap — currently 16 points behind, the largest single contributor to IMVT's edge.
- 2IMNM's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3IMVT's conflicting signal state resolves bearish — it currently carries 4 bullish and 3 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
IMVT leads on balance| Metric | IMNM | IMVT |
|---|---|---|
| Revenue growth (YoY) | 0% | -100% |
| EPS growth (YoY) | -16.9% | 37.3% |
| Gross margin | 0% | 100% |
| Operating margin | 0% | -74.9% |
| Return on equity (TTM) | -18.9% | -14.8% |
| Debt to equity | 0.03 | 0 |
Performance
IMVT leads 6 of 6 windows| Metric | IMNM | IMVT |
|---|---|---|
| 1 week (5 sessions) | 0.3% | 12% |
| 1 month (20 sessions) | 14% | 27.9% |
| 3 months (63 sessions) | -31.5% | -21.8% |
| 6 months (126 sessions) | -10.1% | 24.3% |
| Year to date | -12.6% | 34.5% |
| 1 year (252 sessions) | 7.7% | 45.8% |
Technicals
IMVT has the stronger structure| Metric | IMNM | IMVT |
|---|---|---|
| RSI (14) | 46.9 | 58.1 |
| ADX (14) | 24.1 | 33.1 |
| Price vs 50-day | -9.1% | 4.7% |
| Price vs 200-day | -15.5% | 5.7% |
| Volatility (1M, annualized) | 61.4% | 72.6% |
Risk
IMVT is the more resilient| Metric | IMNM | IMVT |
|---|---|---|
| Beta | 1.47 | 1.58 |
| Sharpe ratio | 0.45 | 0.9 |
| Sortino ratio | 0.68 | 1.77 |
| Max drawdown | -44.8% | -40.5% |
| Current drawdown | -37.1% | -24% |
| Annualized volatility | 60.7% | 58.6% |
| Value at risk (95%) | -5.6% | -4.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, IMNM or IMVT?
On the Algovestiq AIQ Score, IMVT is the stronger of the two as of Nov 15, 2026, scoring 52 against IMNM's 48. The edge comes from momentum and risk resilience. IMNM is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is IMNM or IMVT the better buy right now?
IMVT carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 4 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 4 points. Treat the lead as provisional.
Why does the AIQ Score favor IMVT over IMNM?
The composite weights Quality, Value, Momentum and Risk Resilience. IMVT leads Momentum by 16 points; IMNM leads Quality by 10 points; IMVT leads Risk Resilience by 5 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, IMNM or IMVT?
Analyst price targets imply +43.8% upside for IMNM and not covered for IMVT. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, IMNM or IMVT?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, IMNM or IMVT?
IMNM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, IMNM or IMVT?
IMVT on the Momentum factor, by 16 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, IMNM or IMVT?
IMVT is the more resilient of the two, so the other name carries the higher downside risk. IMVT on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is IMNM more profitable than IMVT?
IMVT leads on the comparable margin measures — gross margin 0% vs 100%; operating margin 0% vs -74.9%; ttm roe -18.9% vs -14.8%.
Is IMVT's lead over IMNM getting stronger or weaker?
IMVT lead: Reversed — IMNM led by 2 AIQ points 30 sessions ago; IMVT now leads by 4. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-11-09, when IMVT moved ahead of IMNM.
What would change the IMNM vs IMVT verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IMNM closes the Momentum gap — currently 16 points behind, the largest single contributor to IMVT's edge; IMNM's Death Cross Active resolves — a bearish trend rule currently active against it; IMVT's conflicting signal state resolves bearish — it currently carries 4 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about IMNM and IMVT?
IMNM: 0 bullish / 3 bearish / 2 neutral. IMVT: 4 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on IMNM is Death Cross Active (bearish, long horizon). On IMVT it is Golden Cross Active (bullish, long horizon).
Compare IMNM and IMVT with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.